|Articles|September 1, 2019
- BioPharm International-09-01-2019
- Volume 32
- Issue 9
BioPharm International, September 2019 Issue (PDF)
Click the title above to open the BioPharm International September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Improving Oligonucleotide Analysisover 6 years ago
Dealing with particulates or aggregates in biologicsover 6 years ago
Putting Biopharma Stability Testing Under the Microscopeover 6 years ago
What’s New in Manufacturing: Process Chromatographyover 6 years ago
More Predictable Post-Approval Change Policy on Horizonover 6 years ago
Best Practices for Studying Stability in Biologicsover 6 years ago
Developing an Effective Contamination Control Strategyover 6 years ago
Biologics Continue to Grow and Create Outsourcing Opportunitiesover 6 years ago
Plan Now to Share Your Expertise in 2020Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
